Calendar Lotus Pharmaceutical Co., Ltd.

Equities

1795

TW0001795003

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 2025-12-12			5-day change	1st Jan Change
277.50 ^TWD	-1.94%		-6.72%	+2.97%

12-02	Lotus Pharmaceutical Co., Ltd. completed the acquisition of remaining majority stake in New Alvogen Group Holdings, Inc.	CI
12-01	Lenz Therapeutics, Lotus Pharmaceutical Say New Drug Application for Presbyopia Treatment Submitted in South Korea	MT

Chart calendar Lotus Pharmaceutical Co., Ltd.

2.wJdwthjZU_tn8nuFckYBzHLICW_6TwsBJ5bdmNKQo-M.9-Eh9XLoIrUSwzizSiRv-SGEa1mif05Xb-GZ4YDl0ZuTwzbBNe4xiA2nPg~5550125a4ea3bafb36c75e78d84a83e5

Upcoming events on Lotus Pharmaceutical Co., Ltd.

2026-03-11	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-05-06	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-08-05	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-11-04	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Lotus Pharmaceutical Co., Ltd.

2025-12-10	November 2025 Sales and Revenue Release
2025-11-12	Q3 2025 Earnings Release
2025-11-10	October 2025 Sales and Revenue Release
2025-10-09	September 2025 Sales and Revenue Release
2025-09-10	August 2025 Sales and Revenue Release
2025-08-15	Morgan Stanley Investor Conference
2025-08-11	July 2025 Sales and Revenue Release
2025-08-10	Q2 2025 Earnings Release
2025-07-10	June 2025 Sales and Revenue Release
2025-06-25	Annual General Meeting
2025-06-10	May 2025 Sales and Revenue Release
2025-05-09	Q1 2025 Earnings Release
2025-05-09	April 2025 Sales and Revenue Release
2025-04-08	March 2025 Sales and Revenue Release
2025-03-10	February 2025 Sales and Revenue Release
2025-03-06	Q4 2024 Earnings Release
2025-02-10	January 2025 Sales and Revenue Release
2025-01-10	December 2024 Sales and Revenue Release
2024-12-10	November 2024 Sales and Revenue Release
2024-11-19	Morgan Stanley Asia Pacific Summit

Past dividends on Lotus Pharmaceutical Co., Ltd.

2025-08-10	Annual 5.778591 TWD
2024-08-04	Annual 4.647452 TWD
2023-07-04	Other Dividend 3.459921 TWD
2022-08-03	Other Dividend 1.931215 TWD
2021-07-06	Annual 0.35 TWD
2011-09-26	Annual 0.3 TWD
2010-09-07	Annual 0.1 TWD
2009-08-11	Annual 0.2 TWD
2008-08-13	Annual 1 TWD
2007-08-01	Annual 1 TWD
2006-08-02	Annual 0.8 TWD

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million TWD	Released Forecast Spread	14 633 14 393 1.67%	16 958 17 025 -0.39%	18 584 18 469 0.62%	19 419	31 842	37 716
EBITDA Million TWD	Released Forecast Spread	5 048 4 930 2.4%	6 114 6 401 -4.49%	7 303 6 934 5.33%	7 324	12 290	13 878
EBIT Million TWD	Released Forecast Spread	4 111 4 164 -1.28%	4 903 5 407 -9.33%	6 020 6 133 -1.84%	5 903	9 936	12 361
Earnings before Tax (EBT) Million TWD	Released Forecast Spread	3 940 3 977 -0.93%	5 103 5 139 -0.71%	6 360 5 973 6.48%	5 793	9 157	11 407
Net income Million TWD	Released Forecast Spread	3 021 3 099 -2.52%	4 106 4 090 0.37%	5 066 4 810 5.3%	4 693	7 221	8 851
EPS TWD	Released Forecast Spread	11,6 12,0 -3.14%	15,7 15,6 1.05%	19,4 18,3 5.93%	17,8	27,3	33,6
Announcement Date		14/03/23	15/03/24	07/03/25	-

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million TWD	Released Forecast Spread	4 198 4 237 -0.92%	4 743 5 004 -5.21%	5 234 5 217 0.32%	4 409 4 266 3.36%	4 730 4 456 6.16%	4 747 5 168 -8.15%	4 771 4 731 0.84%	5 222	8 090	8 479	8 812	8 701
EBITDA Million TWD	Released Forecast Spread	1 572 1 352 16.28%	1 944 2 268 -14.27%	2 439 2 306 5.78%	1 347 1 820 -25.97%	2 066 2 217 -6.8%	1 871 2 638 -29.07%	1 559 1 945 -19.84%	2 519
EBIT Million TWD	Released Forecast Spread	1 256 1 455 -13.73%	1 633 1 827 -10.63%	2 112 2 052 2.92%	1 019 1 147 -11.13%	1 715 1 348 27.25%	1 504 1 840 -18.28%	1 193 1 501 -20.55%	1 491	2 409	2 697	2 904	2 809
Earnings before Tax (EBT) Million TWD	Released Forecast Spread	1 306 1 390 -6.03%	1 661 1 776 -6.48%	1 898 2 018 -5.97%	1 494 1 113 34.23%	1 742 1 295 34.49%	827 1 727 -52.09%	1 832 1 480 23.8%	1 391	2 127	2 407	2 606	2 512
Net income Million TWD	Released Forecast Spread	1 036 1 086 -4.56%	1 332 1 398 -4.75%	1 565 1 603 -2.38%	1 133 883 28.22%	1 435 1 028 39.56%	728 1 384 -47.38%	1 435 1 183 21.28%	1 095	1 639	1 859	2 017	1 945
EPS TWD	Released Forecast Spread	3,94 4,14 -4.92%	5,09 5,32 -4.29%	5,98 6,09 -1.81%	4,32 3,35 29.15%	5,47 3,90 40.26%	2,79 5,23 -46.69%	5,53 4,50 22.96%	4,16	6,22	7,06	7,66	7,38
Announcement Date		11/05/24	08/08/24	07/11/24	07/03/25	09/05/25	13/08/25	14/11/25	-	-	-	-	-

Upcoming sector events for Lotus Pharmaceutical Co., Ltd.

2026-01-05	HISAMITSU PHARMACEUTICAL CO., INC.	Q3 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-11	TILRAY BRANDS, INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-15	SUPRIYA LIFESCIENCE LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-20	JOHNSON & JOHNSON	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-20	HANALL BIOPHARMA CO., LTD.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-21	LAURUS LABS LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-21	ALIVUS LIFE SCIENCES LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-21	TORRENT PHARMACEUTICALS LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-22	DR. REDDY'S LABORATORIES LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-26	GRANULES INDIA LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for Lotus Pharmaceutical Co., Ltd.

2025-12-10	SYNMOSA BIOPHARMA CORPORATION	November 2025 Sales and Revenue Release
2025-12-10	LOTUS PHARMACEUTICAL CO., LTD.	November 2025 Sales and Revenue Release
2025-12-09	MEDINCELL S.A.	Q2 2026 Earnings Release
2025-12-09	CENTER LABORATORIES, INC.	November 2025 Sales and Revenue Release
2025-12-09	BORA PHARMACEUTICALS CO., LTD.	November 2025 Sales and Revenue Release
2025-12-05	TTY BIOPHARM COMPANY LIMITED	November 2025 Sales and Revenue Release
2025-11-30	INVENTAGE LAB, INC.	Q3 2025 Earnings Release
2025-11-27	DOTTIKON ES HOLDING AG	Q2 2026 Earnings Release
2025-11-19	CSPC PHARMACEUTICAL GROUP LIMITED	Q3 2025 Earnings Release
2025-11-14	SEQUENT SCIENTIFIC LIMITED	Q2 2026 Earnings Release